AU2003251474A1 - Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity - Google Patents

Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity

Info

Publication number
AU2003251474A1
AU2003251474A1 AU2003251474A AU2003251474A AU2003251474A1 AU 2003251474 A1 AU2003251474 A1 AU 2003251474A1 AU 2003251474 A AU2003251474 A AU 2003251474A AU 2003251474 A AU2003251474 A AU 2003251474A AU 2003251474 A1 AU2003251474 A1 AU 2003251474A1
Authority
AU
Australia
Prior art keywords
aminocyclohexene
quinolines
antibacterial activity
azaisosteric
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003251474A
Other languages
English (en)
Other versions
AU2003251474A8 (en
Inventor
David Thomas Davies
John Stephen Elder
Andrew Keith Forrest
Richard Lewis Jarvest
Neil David Pearson
Robert John Sheppard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003251474A1 publication Critical patent/AU2003251474A1/en
Publication of AU2003251474A8 publication Critical patent/AU2003251474A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU2003251474A 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity Abandoned AU2003251474A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0217294.8 2002-07-25
GBGB0217294.8A GB0217294D0 (en) 2002-07-25 2002-07-25 Medicaments
PCT/EP2003/008153 WO2004014361A1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity

Publications (2)

Publication Number Publication Date
AU2003251474A1 true AU2003251474A1 (en) 2004-02-25
AU2003251474A8 AU2003251474A8 (en) 2004-02-25

Family

ID=9941121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003251474A Abandoned AU2003251474A1 (en) 2002-07-25 2003-07-23 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity

Country Status (9)

Country Link
US (1) US20060040925A1 (enExample)
EP (1) EP1539133B1 (enExample)
JP (1) JP4515260B2 (enExample)
AT (1) ATE336995T1 (enExample)
AU (1) AU2003251474A1 (enExample)
DE (1) DE60307860T2 (enExample)
ES (1) ES2270142T3 (enExample)
GB (1) GB0217294D0 (enExample)
WO (1) WO2004014361A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AU2003239302A1 (en) * 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
EP1470125A1 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine derivatives
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
AR040335A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
DE60331849D1 (de) 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
ES2350977T3 (es) 2002-11-05 2011-01-28 Glaxo Group Limited Agentes antibacterianos.
US7491714B2 (en) 2002-12-04 2009-02-17 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
AR042486A1 (es) * 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
WO2006002047A2 (en) * 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
WO2006010040A2 (en) * 2004-07-09 2006-01-26 Glaxo Group Limited Antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
ES2376488T3 (es) 2006-01-26 2012-03-14 Actelion Pharmaceuticals Ltd. Antibióticos de tetrahidropirano.
EP1991540A1 (en) * 2006-02-21 2008-11-19 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
JP2009528365A (ja) * 2006-02-28 2009-08-06 アムゲン インコーポレイティッド ホスホジエステラーゼ10阻害剤としてのシンノリン及びキナゾリン誘導体
MX2008011257A (es) * 2006-03-08 2008-09-25 Amgen Inc Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10.
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
PL2137196T3 (pl) * 2007-04-20 2011-03-31 Glaxo Group Ltd Tricykliczne związki zawierające azot jako środki przeciwbakteryjne
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
EP2379554B1 (en) 2009-01-15 2015-11-11 Glaxo Group Limited Naphthyridin-2(1h)-one compounds useful as antibacterials
AR089929A1 (es) 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
JP6022691B2 (ja) * 2012-08-30 2016-11-09 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ジオキシノ−及びオキサジン−[2,3−d]ピリミジンpi3k阻害剤化合物及び使用方法
EA031589B1 (ru) 2014-08-22 2019-01-31 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae
ES2882667T3 (es) 2015-08-07 2021-12-02 Bayer Cropscience Ag Derivados heterocíclicos condensados sustituidos por 2-(het)arilo como pesticidas
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
WO2021076886A1 (en) 2019-10-18 2021-04-22 The Regents Of The University Of California 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders
CN119161260A (zh) * 2024-06-26 2024-12-20 安徽大学 一种1-(2-氨基-4-氟-5-甲氧基苯基)-1-丙酮的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0790981B1 (en) * 1994-11-10 1999-09-08 Pfizer Inc. Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
WO1999037635A1 (en) * 1998-01-26 1999-07-29 Smithkline Beecham Plc Quinoline derivatives as antibacterials
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
GB9914486D0 (en) * 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917406D0 (en) * 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917408D0 (en) * 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
EP1305308B1 (en) * 2000-07-26 2006-12-20 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
FR2816618B1 (fr) * 2000-11-15 2002-12-27 Aventis Pharma Sa Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent
GB0031088D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
EP1539133B1 (en) 2006-08-23
DE60307860T2 (de) 2007-10-11
WO2004014361A9 (en) 2004-04-08
GB0217294D0 (en) 2002-09-04
WO2004014361A1 (en) 2004-02-19
ES2270142T3 (es) 2007-04-01
AU2003251474A8 (en) 2004-02-25
JP2005538125A (ja) 2005-12-15
US20060040925A1 (en) 2006-02-23
EP1539133A1 (en) 2005-06-15
JP4515260B2 (ja) 2010-07-28
ATE336995T1 (de) 2006-09-15
DE60307860D1 (de) 2006-10-05

Similar Documents

Publication Publication Date Title
AU2003251474A1 (en) Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
MXPA03000708A (es) Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana.
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
GB0112836D0 (en) Medicaments
AU2003291227A1 (en) Antibacterial agents
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
GB0101577D0 (en) Compounds
GB0031088D0 (en) Medicaments
AU6825300A (en) Compounds
MXPA03010790A (es) Heterociclos biciclicos que contienen nitrogeno para uso como antibacterianos.
WO2004058144A3 (en) Antibacterial agents
EP1560821B8 (en) Antibacterial agents
AU2002218192A1 (en) Quinoline derivatives as antibacterials
TW200507841A (en) Antibacterial agents
WO2001007432A8 (en) Aminopiperidine derivatives as antibacterials
AU2003294565A1 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EP1781669A4 (en) ANTIBACTERIAL AGENTS